Scienmag

APRIL 9, 2022

NEW ORLEANS – A new chimeric antigen receptor (CAR) T-cell product had an acceptable safety profile and showed early signs of efficacy as a monotherapy and in combination with an mRNA vaccine in patients with solid tumors, according to preliminary data from a phase I/II clinical trial presented during the AACR Annual Meeting 2022, held […].

Clinical Trials 63

Clinical Trials Clinical Trials Vaccination Vaccine 63

Drug Patent Watch

APRIL 9, 2022

Annual Drug Patent Expirations for LEXISCAN Lexiscan is a drug marketed by Astellas and is included in one NDA. It is available from two suppliers. There are three patents protecting…. The post New patent expiration for Astellas drug LEXISCAN appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

APRIL 9, 2022

This chart shows the pharmaceutical companies with the most patents in Russian Federation. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…. The post Which pharmaceutical companies have the most drug patents in Russian Federation? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 40

Drugs 40